Stockscreener 앱 받기
77.81
1.47%
1.13
시간 외 거래:
77.81
전일 마감가:
$76.68
열려 있는:
$76.69
하루 거래량:
6.25M
Relative Volume:
2.81
시가총액:
$9.10M
수익:
$947.36M
순이익/손실:
$392.47M
주가수익비율:
25.76
EPS:
3.02
순현금흐름:
$392.71M
1주 성능:
+1.18%
1개월 성능:
+11.19%
6개월 성능:
+21.01%
1년 성능:
+30.77%
1일 변동 폭
$76.17
$77.95
1주일 범위
$75.19
$77.95
52주 변동 폭
$42.01
$77.95
Halozyme Therapeutics Inc Stock (HALO) Company Profile
명칭
Halozyme Therapeutics Inc
전화
(858) 794-8889
주소
12390 EL CAMINO REAL, SAN DIEGO, CA
HALO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HALO
Halozyme Therapeutics Inc
|
77.81 | 8.97B | 947.36M | 392.47M | 392.71M | 3.02 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Halozyme Therapeutics Inc Stock (HALO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-06 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-10 | 재개 | Goldman | Neutral |
| 2025-05-14 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | 다운그레이드 | Leerink Partners | Market Perform → Underperform |
| 2024-10-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-09-19 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-06-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-02-29 | 개시 | TD Cowen | Outperform |
| 2023-07-24 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-07-24 | 개시 | H.C. Wainwright | Buy |
| 2023-05-10 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-03-27 | 재개 | Berenberg | Buy |
| 2023-03-16 | 다운그레이드 | SVB Securities | Outperform → Market Perform |
| 2022-12-21 | 재개 | Morgan Stanley | Overweight |
| 2022-11-28 | 개시 | Wells Fargo | Overweight |
| 2022-09-09 | 개시 | Morgan Stanley | Overweight |
| 2022-05-23 | 개시 | SVB Leerink | Outperform |
| 2021-06-14 | 개시 | Evercore ISI | Outperform |
| 2021-05-17 | 개시 | SVB Leerink | Outperform |
| 2021-05-11 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-01-21 | 재확인 | The Benchmark Company | Buy |
| 2020-12-17 | 개시 | Berenberg | Buy |
| 2020-09-14 | 재개 | JP Morgan | Overweight |
| 2020-07-01 | 개시 | The Benchmark Company | Buy |
| 2020-02-05 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2020-01-09 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2020-01-08 | 개시 | Goldman | Buy |
| 2019-11-05 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2018-10-19 | 재개 | Piper Jaffray | Neutral |
| 2018-05-11 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-16 | 재확인 | Piper Jaffray | Overweight |
| 2017-01-06 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2016-11-03 | 개시 | Deutsche Bank | Buy |
| 2015-12-04 | 개시 | Wells Fargo | Outperform |
| 2015-11-18 | 개시 | Citigroup | Buy |
| 2015-09-22 | 개시 | Barclays | Overweight |
| 2015-06-22 | 재확인 | JP Morgan | Overweight |
| 2015-03-03 | 재확인 | UBS | Buy |
| 2015-02-18 | 재확인 | MLV & Co | Buy |
| 2015-01-08 | 재확인 | MLV & Co | Buy |
모두보기
Halozyme Therapeutics Inc 주식(HALO)의 최신 뉴스
Halozyme Therapeutics (NASDAQ:HALO) Sets New 1-Year HighHere's What Happened - MarketBeat
Strs Ohio Buys Shares of 30,000 Halozyme Therapeutics, Inc. $HALO - MarketBeat
Livforsakringsbolaget Skandia Omsesidigt Acquires 44,700 Shares of Halozyme Therapeutics, Inc. $HALO - MarketBeat
Halozyme Therapeutics, Inc. $HALO Shares Sold by Livforsakringsbolaget Skandia Omsesidigt - MarketBeat
Halozyme Therapeutics, Inc. $HALO Shares Sold by NorthCrest Asset Manangement LLC - MarketBeat
FOMO Trade: What drives Halozyme Therapeutics Inc.’s stock price2025 Market WrapUp & Reliable Momentum Entry Alerts - khodrobank.com
Swedbank AB Sells 26,100 Shares of Halozyme Therapeutics, Inc. $HALO - MarketBeat
Market Catalysts: What is PSNY’s book value per share2025 Key Highlights & Advanced Technical Analysis Signals - khodrobank.com
Halozyme Therapeutics stock hits all-time high at 77.6 USD - Investing.com
Halozyme Therapeutics stock hits all-time high at 77.6 USD By Investing.com - Investing.com UK
Halozyme Therapeutics, Inc. (HALO) Hikes 2025 Guidance on ENHANZE Demand - MSN
Halozyme Therapeutics (HALO) Is Up 2.63% in One Week: What You Should Know - Yahoo Finance
Aug Analyst Calls: Will Halozyme Therapeutics Inc benefit from geopolitical trends2025 Macro Impact & Weekly Market Pulse Updates - khodrobank.com
Are Medical Stocks Lagging atai Life Sciences (ATAI) This Year? - Yahoo Finance
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar - Yahoo Finance
Goldman Sachs Group Inc. Has $96.92 Million Position in Halozyme Therapeutics, Inc. $HALO - MarketBeat
Redhawk Wealth Advisors Inc. Acquires 4,827 Shares of Halozyme Therapeutics, Inc. $HALO - MarketBeat
Ashton Thomas Private Wealth LLC Invests $266,000 in Halozyme Therapeutics, Inc. $HALO - MarketBeat
Focus Partners Wealth Purchases 44,260 Shares of Halozyme Therapeutics, Inc. $HALO - MarketBeat
Rate Hike: Can Halozyme Therapeutics Inc benefit from deglobalization2025 Pullback Review & AI Powered Buy/Sell Recommendations - khodrobank.com
If You Invested $1000 in Halozyme Therapeutics a Decade Ago, This is How Much It'd Be Worth Now - Yahoo Finance
Financiere des Professionnels Fonds d investissement inc. Acquires New Position in Halozyme Therapeutics, Inc. $HALO - MarketBeat
Where is Halozyme Therapeutics (HALO) Headed According to Analysts? - Yahoo Finance
What is Halozyme Therapeutics Inc.’s book value per shareJuly 2025 Trends & Verified Short-Term Trading Plans - khodrobank.com
What Does the Market Think About Halozyme Therapeutics? - Sahm
Insider Selling: Halozyme Therapeutics (NASDAQ:HALO) CFO Sells 20,000 Shares of Stock - MarketBeat
Halozyme Therapeutics, Inc. $HALO Shares Bought by Intech Investment Management LLC - MarketBeat
HALO Gears Up to Report Q4 Earnings: Here's What You Should Know - MSN
Tech Rally: What are the future prospects of Halozyme Therapeutics Inc2025 Market WrapUp & AI Powered Buy and Sell Recommendations - khodrobank.com
Halozyme up after guidance raise, Morgan Stanley upgrade - MSN
US Market Recap: Will Halozyme Therapeutics Inc. benefit from geopolitical trendsM&A Rumor & AI Enhanced Trading Alerts - khodrobank.com
MRA Advisory Group Acquires Shares of 8,721 Halozyme Therapeutics, Inc. $HALO - MarketBeat
Surprises Report: Is Halozyme Therapeutics Inc stock a falling knife or bargain buyWeekly Stock Recap & Intraday High Probability Alerts - khodrobank.com
EV Market: Should value investors consider ECCCJuly 2025 Drop Watch & Daily Stock Momentum Reports - خودرو بانک
United Services Automobile Association Takes Position in Halozyme Therapeutics, Inc. $HALO - MarketBeat
Published on: 2025-09-16 07:17:30 - khodrobank.com
Dow Update: What are the future prospects of Halozyme Therapeutics IncTrade Signal Summary & Verified Trade Idea Suggestions - khodrobank.com
Trend Review: Will Halozyme Therapeutics Inc benefit from seasonalityJuly 2025 Catalysts & Trade Opportunity Analysis Reports - khodrobank.com
Gap Down: Can Halozyme Therapeutics Inc benefit from deglobalizationJuly 2025 Outlook & Community Verified Watchlist Alerts - khodrobank.com
Insider Buy: Can Halozyme Therapeutics Inc navigate macro headwinds2025 Volatility Report & Weekly Watchlist for Consistent Profits - khodrobank.com
Great Lakes Advisors LLC Purchases 98,190 Shares of Halozyme Therapeutics, Inc. $HALO - MarketBeat
Jacobs Levy Equity Management Inc. Invests $11.64 Million in Halozyme Therapeutics, Inc. $HALO - MarketBeat
Halozyme Therapeutics (NASDAQ:HALO) Reaches New 1-Year HighHere's What Happened - MarketBeat
Halozyme Therapeutics stock hits all-time high at 76.34 USD By Investing.com - Investing.com Australia
Halozyme Therapeutics stock hits all-time high at 76.34 USD - Investing.com
Halozyme Therapeutics Inc (HALO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.43%
0.09%
자본화:
|
볼륨(24시간):